Anova Enterprises Acquires Corlexia Clinical Services
January 31, 2021
Anova Enterprises, Inc. has acquired Corlexia Clinical Services, a contract research organization focused on complex neurology and oncology clinical trials. The acquisition brings Corlexia's staff, studies and client relationships onto Anova's AnovaOS platform to expand Anova's capabilities and clinical site network for neurological indications and other therapeutic areas.
- Buyers
- Anova Enterprises, Inc.
- Targets
- Corlexia Clinical Services
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Clario Acquires NeuroRx
March 19, 2025
Healthcare Services
Clario has acquired NeuroRx, a Montreal-based imaging analysis provider specializing in neuroimaging for clinical trials, to strengthen Clario's neuroscience capabilities. NeuroRx founder Douglas Arnold will join Clario as Senior Scientific Advisor as the company integrates NeuroRx's imaging expertise to support drug development in CNS indications.
-
Avania Acquires Anagram
October 8, 2024
Healthcare Services
Avania, a global MedTech contract research organization (CRO), has acquired Anagram, a Barcelona-based MedTech CRO, to expand its CRO footprint into Spain and Southern Europe. The acquisition adds Anagram’s imaging core lab and therapeutic expertise in cardiology, neurology and oncology, strengthening Avania’s regional presence and clinical capabilities.
-
American Clinical Research Services Acquires Elixia
May 8, 2024
Healthcare Services
American Clinical Research Services (ACRS), a clinical research platform formed by Latticework Capital Management, has acquired Elixia, a multi-specialty clinical research site network operating in Florida, Massachusetts, Michigan and Missouri. The acquisition expands ACRS's footprint and capabilities in complex therapeutic areas—notably nephrology, neuroscience and infectious diseases—and adds Elixia's 40-bed Phase I unit in Tampa to ACRS's national site network.
-
Avance Clinical Acquires C3 Research Associates to Expand into North America
September 6, 2022
Healthcare Services
Avance Clinical, a PE-backed Australian CRO, has acquired North American CRO partner C3 Research Associates to expand its later‑phase clinical trial capabilities and establish a US presence. Backed by private equity firm The Riverside Company, Avance will integrate C3 into its GlobalReady model and invest in growing its North American team to support biotechs transitioning from early‑phase studies in Australia/New Zealand to later phases in the US.
-
Novo Integrated Sciences / Novo Healthnet Acquire Acenzia Inc.
June 29, 2021
Pharmaceuticals
Novo Integrated Sciences, through its wholly owned subsidiary Novo Healthnet Limited, completed the acquisition of Acenzia Inc., a Windsor, Ontario-based nutraceutical manufacturer and diagnostics developer. The all-share transaction closed on June 24, 2021 and is valued at $14,884,039; Novo said the purchase will give it direct control of development, manufacturing and distribution of wellness products and personalized diagnostics.
-
The Clarke Companies Acquires Covex, LLC
January 9, 2020
Professional Services
The Clarke Companies, backed by Lightview Capital, has acquired Covex, LLC to integrate enterprise IT validation and compliance capabilities with Clarke's manufacturing automation and validation services. The add-on expands Clarke's geographic footprint into the Northeast and Southeast and strengthens its ability to serve FDA‑regulated life sciences customers.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.